OpenBilldrug price receipt

NADAC week of 2026-10-14

SEVELAMER 2.4 GM POWDER PACKET

For 1 unit (EA)

Pharmacies pay

$1.01 filed

1 × $1.00501 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$0.84 filed

1 × $0.84463 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.84× estimated

Medicare paid 16% less than pharmacies pay.

Part D averages every strength and form sold under “Sevelamer Carbonate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.16 estimated

$1.01 + $0.15 (15%) + $5.00 fee per fill = $6.16

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

SEVELAMER 2.4 GM POWDER PACKET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “sevelamer carbonate” and “sevelamer carbonate for oral suspension”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “powder, for suspension” and “for suspension” and its route as oral.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Amneal Pharmaceuticals of New York LLC, Macleods Pharmaceuticals Limited and Dr. Reddys Laboratories Inc.

FDA’s Established Pharmacologic Class for it is Phosphate Binder.

The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes); the FDA directory lists 6 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.01 for 1 unit (EA) (1 × $1.00501 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 6 labelers

LabelerNDCsPharmacies pay per unit
Amneal Pharmaceuticals of New York LLC1$1.00501 per EA filed
Aurobindo Pharma Limited1$1.00501 per EA filed
Bionpharma Inc.1$1.00501 per EA filed
Dr. Reddys Laboratories Inc1$1.00501 per EA filed
Macleods Pharmaceuticals Limited1$1.00501 per EA filed
Strides Pharma Science Limited1$1.00501 per EA filed
Not listed as a package in the FDA directory4$1.00501 per EA filed
All 10 NDCs, with labeler and price
  • 00115-1366-29 · Amneal Pharmaceuticals of New York LLC · $1.00501 per EA · eff. 2026-09-23 filed
  • 00115-1366-30 · not listed as a package in the FDA directory · $1.00501 per EA · eff. 2026-09-23 filed
  • 33342-0289-68 · Macleods Pharmaceuticals Limited · $1.00501 per EA · eff. 2026-09-23 filed
  • 43598-0479-01 · not listed as a package in the FDA directory · $1.00501 per EA · eff. 2026-09-23 filed
  • 43598-0479-90 · Dr. Reddys Laboratories Inc · $1.00501 per EA · eff. 2026-09-23 filed
  • 64380-0881-80 · Strides Pharma Science Limited · $1.00501 per EA · eff. 2026-09-23 filed
  • 65862-0931-08 · not listed as a package in the FDA directory · $1.00501 per EA · eff. 2026-09-23 filed
  • 65862-0931-90 · Aurobindo Pharma Limited · $1.00501 per EA · eff. 2026-09-23 filed
  • 69452-0127-19 · Bionpharma Inc. · $1.00501 per EA · eff. 2026-09-23 filed
  • 69452-0127-60 · not listed as a package in the FDA directory · $1.00501 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with SEVELAMER 2.4 GM POWDER PACKET.

ProductPharmacies pay per unitMedicare per unit
RENVELA 800 MG TABLET
brand · tablet, film coated
$5.68515 per EA filed
eff. 2026-04-22
$6.38585 per EA filed
Part D 2024 average
SEVELAMER 0.8 GM POWDER PACKET
generic · powder, for suspension / for suspension
$0.91959 per EA filed
eff. 2026-09-23
$0.84463 per EA filed
Part D 2024 average
SEVELAMER 2.4 GM POWDER PACKET this page
generic · powder, for suspension / for suspension
$1.00501 per EA filed
eff. 2026-09-23
$0.84463 per EA filed
Part D 2024 average
SEVELAMER CARBONATE 800 MG TAB
generic · tablet, film coated / tablet
$0.214 per EA filed
eff. 2026-09-23
$0.84463 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 10 NDCs’ NADAC prices is $1.00501 per EA filed.

Of the 34 other products in FDA’s Phosphate Binder class priced per EA, 13 have a higher middle NADAC price and 21 a lower one. The one in the middle is SEVELAMER CARBONATE 800 MG TAB, at $0.214 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $0.84 for 1 unit (EA), at an average of $0.84463 per EA in 2024 (2024-01-01 to 2024-12-31) for “Sevelamer Carbonate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 767,039 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

8 of the product’s 10 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for SEVELAMER 2.4 GM POWDER PACKET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Sevelamer Carbonate / Sevelamer Carbonate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 6 of its 10 NDCs (it does not list the other 4) as dosage forms “FOR SUSPENSION”, “POWDER, FOR SUSPENSION” with route “ORAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.